A detailed history of Parallax Volatility Advisers, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 2,185 shares of LLY stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,185
Previous 7,300 70.07%
Holding current value
$1.74 Million
Previous $6.61 Million 70.72%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1.69 Million - $2.1 Million
2,185 New
2,185 $1.94 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $184,747 - $254,702
425 New
425 $228,000
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $30 Million - $36.9 Million
-135,225 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $16.1 Million - $20.8 Million
89,074 Added 193.01%
135,225 $31 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $96,948 - $125,504
-590 Reduced 1.26%
46,151 $8.62 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $6.1 Million - $8.07 Million
46,741 New
46,741 $7.89 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $5.05 Million - $6.68 Million
-38,717 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $3.71 Million - $4.29 Million
-25,362 Reduced 39.58%
38,717 $5.73 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $5.23 Million - $6.3 Million
38,358 Added 149.13%
64,079 $10.5 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $14 Million - $17.3 Million
-117,377 Reduced 82.03%
25,721 $3.57 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $5.18 Million - $6.42 Million
48,492 Added 51.26%
143,098 $18.8 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $3.41 Million - $3.71 Million
-31,951 Reduced 25.25%
94,606 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $12.9 Million - $15 Million
116,111 Added 1111.54%
126,557 $14 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $6.22 Million - $7.32 Million
-55,887 Reduced 84.25%
10,446 $1.36 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.33 Million - $2.61 Million
21,961 Added 49.49%
66,333 $7.68 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $3.81 Million - $4.76 Million
44,372 New
44,372 $4.76 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $1.05 Million - $1.21 Million
-13,909 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $677,166 - $799,350
-9,125 Reduced 39.62%
13,909 $1.08 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $1.75 Million - $1.87 Million
21,303 Added 1230.68%
23,034 $1.95 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $133,408 - $148,069
1,731
1,731 $148,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.